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Recent analyses of immunologic specificity have demonstrated that, to a consider- 
able  extent,  antigenic  recognition  involves  not  only  the  recognition  of extrinsic 
antigenic determinants per se, but also the recognition of determinants contributed 
by antigen-presenting cells. For example, antigen-specific T  helper ceils are restricted 
in  collaboration to cells syngeneic with  the  antigen-presenting cell responsible  for 
their stimulation  (1-5).  Similarly, antigen-specific cytolytic T  lymphocytes are re- 
stricted in effector function by the major histocompatibility complex (MHC) 1 of the 
stimulatory antigen-bearing cells (6-9). Such recognition, which apparently dominates 
the T  cell specificity repertoire, has recently been implicated in antigen recognition 
by B cells as well (10-15). However, because many antibodies can bind to antigens in 
the absence of  presenting cells, the portion of  antibody binding that may be dependent 
on antigen presentation in the context of a presenting cell may generally be obscured 
by antibodies in the population capable of binding the antigen per se. 
The present  studies  were carried out  to  determine  at  the  monoclonal level the 
degree to which the antibody repertoire may also be restricted to the recognition of 
antigens in the context of a presenting cell. We have used syngeneic cell lines infected 
with the PR8 influenza strain  (PR8)  to stimulate individual primary B cells in the 
splenic focus system (16). This has permitted us to analyze the murine B cell repertoire 
specific for PR8 antigens as they are expressed on the cell surface and also to determine 
the extent to which  the  B  cell repertoire may recognize PR8  determinants  in  the 
context of the immunizing syngeneic infected cell line. We have previously reported 
that the response to such a complex antigen is comprised of (a) monoclonal antibodies 
that recognize influenza determinants that are expressed on the isolated virion as well 
as on the cell surface of infected cells and  (b) monoclonal antibodies that recognize 
the influenza determinants only when they are presented in the context of the infected 
cell (16). In this report, we explored the latter recognition in terms of the specific viral 
and  cellular determinants  that  are  necessary for the  binding  of these  monoclonal 
antibodies.  These analyses  have  taken  advantage  of the  availability of both  viral 
variants and H-2 mutants to define the specificity of such antibodies with apparent 
dual specificity. The findings indicate that a large proportion ofsyngeneic monoclonal 
antibodies specifically recognize determinants of the PR8 hemagglutinin (HA) as well 
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as H-2 antigenic determinants expressed on the cell surface and that  the binding of 
these antibodies requires the simultaneous expression of both of these antigens. 
Materials  and  Methods 
Mice.  Adult C3H/HeJ,  BALB.K, C3H.SW, and C57BL/10 mice were obtained from the 
mouse breeding colony at Scripps Clinic and Research Foundation. Individuals 6-8 wk of age 
were used in the splenic fragment cultures. Neonatal mice 10-15 d old used in preparation of 
1  °  kidney cell cultures were also obtained from the mouse breeding colony at Scripps Clinic 
and  Research  Foundation.  These  included  BALB/c,  C57BL/10,  BALB.B,  C3H.OH, 
B10.A(4R), B10.A(5R), D2.GD, and the following H-2K  b mutant strains: B6-C-H-2  bml, B6-C- 
H-2  bin4, B6-C-H-2  bins, B6-C-H-2  bin9, B6-C-H-2bmt~ and B6.C-H-2  bran. 
Viruses.  Influenza virus PR8(A/PR/8/34[H1N1])  was obtained in the form of infectious 
allantoic fluid from Flow Laboratories, Inc., Rockville, Md. The following influenza A virus 
strains were obtained from Dr. Walter Gerhard, Wistar Institute, Philadelphia, Pa.: WSE(A/ 
WSE/33[H1N2]);  MEL(A/MEL/35[H1N1]);  BEL(A/BEL/42[H1N1]);  BH(A/BH/35/ 
[H1N1]);  WEISS(A/WEISS/43[HIN1]);  CAM(A/CAM/46[H1N1]);  and  the  recombinant 
virus Eq-PR8(A/Equine/Miami/1/63[Heq-2]-A/PR8/34[N1]).  All virues were grown in the 
allantoic cavity of 10-11-d embryonated eggs. Upon isolation, the allantoic fluid was titered for 
hemagglutination activity and stored in  1-ml aliquots at -70°C until use. Virus was purified 
by adsorption to and  elution from  chicken  erythrocytes followed by banding in  a  15-45% 
sucrose gradient in an SW27 rotor by centrifugation at  18,000  rpm for 25 min (17).  Purified 
virus was used in the radioimmunoassay as described previously (16,  18, 19). 
Spleen Fragment Cultures.  Spleen fragment cultures were carried out as described previously 
(16) for the stimulation of donor spleen cells with PR8-infected tumor cells. In both H-2  b and 
H-2  k haplotype  mice,  antigen-primed  recipients syngeneic to  the  donor  cells  at  H-2  and 
allogeneic at the heavy chain allotype locus were used to maximize T cell help while minimizing 
antibody-specific suppression of totally syngeneic responses  (19).  Antigenic stimulation was 
6  k  accomplished by intravenous injection of 2 ×  10  PRS-infected L929 (H-2) cells for BALB.K 
(H-2  ~) donor cells and 2 ×  108 PR8-infected EL-4 (H-2  b) cells for C57BL/10 (H-2  b) donor cells. 
C3H/HeJ  (H-2  k) mice and C3H.SW  (H-2  b) mice were used as recipients for BALB.K donor 
spleen cells and C57BL/10 donor spleen cells, respectively. In both cases, recipients were primed 
with 1 ×  107 PR8-infected cells of the appropriate type in alum and used 3-4 wk after priming. 
Cell Cultures.  BALB 3T3 clone 31  fibroblasts were obtained from the Cell Center at Salk 
Institute, La Jolla, Calif. L929 cells were obtained from Dr. Rolf Zinkernagel, previously from 
Scripps Clinic and Research Foundation. These cells were grown in Dulbecco's modified Eagle's 
medium (DMEM) containing 10% newborn calf serum (Irvine Scientific, Irvine, Calif.) and 50 
#g/ml gentamicin (Scherring Corp., Kenilworth, N. J.). When infected with virus, the cells 
were  removed  from  the  monolayer with  0.25%  trypsin and  0.024M  EDTA  in  phosphate- 
buffered saline, pH 7.2 (PBS). 50 hemagglutination units of infectious virus in allantoic fluid 
were added to 2 ×  106 cells in serum-free DMEM and incubated at 37 ° on  10% CO2 for 4 h. 
The cells were then centrifuged, washed two times in DMEM with  10% newborn calf serum, 
and used for the preparation of assay plates as described below. 
PrimaEv Cell Culture.  Kidneys to be used for the preparation of primary cell cultures were 
excised aseptically from  10-15-d neonates and placed in sterile PBS. They were then teased 
apart with forceps and placed in PBS containing 0.25% trypsin and 0.024M EDTA. The kidney 
tissue was stirred gently at room temperature for  10 rain, then the supernate was decanted. 
Additional trypsin-EDTA was added, and the fragments were stirred gently at 4°C overnight. 
The  cell suspension was then  centrifuged at  12,000  rpm  for 8  rain at  4°C.  The cells were 
resuspended  in  DMEM  with  10%  fetal calf serum  and  placed in  two T-75  flasks for each 
neonate used. The cells were incubated at  37°C  in  10% CO2  for 3 d  and then used for the 
preparation of cell assay plates as described below. 
Preparation of Cellular Immunoadsorbents.  Cell assay plates were prepared as described previ- 
ously (16) except that poly-L-lysine (18,000  to 100,000 mol wt; Sigma Chemical Company, St. 
Louis, Mo.) was used in coating wells of polyvinyl plates in place of fetal bovine serum. Plates 
were incubated at room temperature for 1-2 h with 0.1 ml of poly-L-lysine (10 mg/100 ml of 
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Radioimmunoassay.  25/xl  of culture supernatants collected between days 9 and 21 of fragment 
culture were assayed for the presence of antibody through the use of a solid-phase  radioim- 
munoassay, as previously described  (16, 18-20).  Pooled supernatants of each positive culture 
were assessed for specific reactivity using a panel of viruses or virus-infected  cells. According to 
previously established criteria (20), reactivity to any given target was judged negative if binding 
was <10% of that  to the homologous target.  Positive  reactivity was generally 380% of the 
binding of the monoclonal antibody to the homologous target. 
Results 
The  Frequency of Monoclonal Responses Restricted to PR8-infected  Cells.  In a  previous 
report (16), we presented the experimental procedures required to maximize in vitro 
monoelonal  responses  by  B  cells  derived  from  nonimmune  BALB.K  mice  (H-2  k) 
stimulated  with  syngeneic PR8-infected  tumor cells.  It was demonstrated  that  ap- 
proximately one-third of the monoclonal antibodies were capable of binding deter- 
minants on the isolated virion and that these antibodies were equivalent in frequency 
and diversity to those derived by stimulation with the isolated virion per se in terms 
of the recognition of available HA and neuraminidase (NA) determinants. 58% of the 
monoelonal antibodies bound only to PR8-infected tumor cells and not to the isolated 
virion. To determine whether such recognition was a  novel property related in some 
way to the transformed state of the cell used in screening, the antibodies were next 
analyzed for their capacity to bind PRS-infected primary kidney fibroblasts derived 
from BALB.K mice. 94% of the antibodies that bound  PR8 in the context of L929 
cells were also capable of binding PR8 in the context of BALB.K kidney fibroblasts. 
Because primary kidney cells, unlike L929 cells, are capable of  supporting a productive 
influenza  infection  (21),  the  reactivity  of these  antibodies  with  infected  BALB.K 
kidney fibroblasts demonstrates that the vast majority of antibodies recognizing only 
infected cells are not recognizing PR8 determinants unique  to the L929 tumor cell, 
nor determinants expressed only on nonproductively infected cells. 
A  similar  analysis  was  carried  out  with  nonimmune  C57BL/10  B  cells  (H-2  ~) 
responsive to syngeneie PR8-infected EL-4 cells. The overall frequency of the response 
as  assayed  on  PR8-infected  BALB.B  cells  was  1  in  40,000  B  cells.  66%  of these 
antibodies bound PR8 in the context of infected BALB.B cells and not isolated PR8 
virion. 
To dissect the fine specificity of those monoclonal antibodies that required for their 
binding the expression of both viral and cell surface antigens, we included for further 
analysis only those antibodies that demonstrated reactivity with PR8-infected synge- 
neic kidney fibroblasts but not with either uninfected cells or the purified virion. In 
addition, culture fluids that demonstrated partial reactivity (>10% but <80% of the 
binding to the homologous PR8-infeeted cell line)  to any one of the tested infected 
cell targets were considered  ambiguous in their specificity and were excluded  from 
further  consideration.  The  use  of these  criteria  arbitrarily  excluded  from  further 
analysis all  antibodies whose binding may have been  influenced  by other antigens 
indigenous to the tumor cell lines or antigens peculiar to a  nonproductive infection. 
In  spite  of  the  exclusion  of  all  antibodies  with  potentially  ambiguous  binding 
specificity, the monoclonal antibodies that fulfilled the above criteria and were thus 
included in the analyses below represented the products of a majority of nonimmune 
BALB.K or C57BL/10  spleen  cells  responsive to  PR8-infected  L929  or EL-4 cells, 
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The Fine Specificity for  Viral Determinants of PR8-infected Cell-specific Monoclonal Anti- 
bodies.  To determine which viral antigens were recognized by antibodies specific for 
PRS-infected H-2  k cells 112 monoclonal antibodies were analyzed for their capacity 
to bind L929 cells infected with equine PR8, which differs in HA but shares NA and 
other viral proteins with PR8.  19% of the antibodies that bound PR8-infected L929 
cells  were  capable  of binding equine  PRS-infected  L929  cells;  thus,  81%  of the 
antibodies apparently recognized the HA moiety. Table I presents an analysis of the 
specificity for HA of 34 monoclonal antibodies using a  panel of L929 cells infected 
with one of six H 1 influenza strains that are antigenically cross-reactive with PR8. It 
can be seen that over one-half of these antibodies recognized only PR8 and none of 
the other six strains. Additionally, most of those antibodies that bound to other H 1 
HA in the context of L929 cells bound to only one or two additional viruses. These 
findings contrast with previously reported reactivity patterns obtained for monoclonal 
antibodies that recognize determinants on the purified virion generated by stimulation 
with either the purified PR8 virion or with PR8-infected L929 cells, wherein many 
monoclonal antibodies recognized HA determinants common to several H1  strains 
(16,  18). 
In an effort  to conserve antibodies for analyses of H-2 recognition, only a  small 
survey was carried out with monoclonal antibodies derived from C57BL/10 B  cells 
that recognized PR8-infected BALB.B kidney fibroblasts. Of 14 antibodies analyzed, 
12 demonstrated differential recognition amongst BALB.B kidney fibroblasts infected 
with the various H1  influenza strains (data not shown). Thus, the vast majority of 
monoclonal antibodies specific for PR8-infected H-2  b cells recognized determinants 
on the PRS-HA molecule. 
The Fine Specificity  for H-2 Antigenic Determinants of PR8-infected Cell-specific Monoclonal 
Antibodies.  The above results clearly demonstrate that  a  substantial proportion of 
monoclonal  antibodies  can  be  highly  virus-specific  and  yet  their  recognition  is 
dependent  on  cellular  presentation.  Whereas  it  is  possible  that  such  antibodies 
TABLE  I 
Reactivity Pattern Analysis of PR8 (H  l N1)-infected Cell-specific Monoclonal Antibodies against Cells 
Infected with Heterologous H I  Viral  Strains* 
BH  +  +  +  -  +  -  -  - 
WSE  +  +  -  +  -  +  -  - 
MEL  +  -  +  +  -  -  +  - 
WEISS  CAM  BEL 
+  +  +  --  --  --  3,  .... 
-  +  +  .......  3 
+  -  +  .......  3 
+  +  ........  3 
--  --  +  .......  21 
-  +  ........  3 
+  .....  3  --  3  --  6 
..........  52 
* The monoclonal antibodies in this analysis were obtained from BALB.K donor spleen cells stimulated 
with PR8-L929 cells and include only those that  recognized both PR8-infected L929 cells and Pg8- 
infected BALB.K primary kidney cells but not purified virus or uninfected cells form both sources. 
:l: Results are expressed as the percentage of 34 monoclonal antibodies showing a particular reactivity 
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recognize complex determinants  that  include  both  viral  and  cell  surface antigenic 
contributions,  it  is  also  possible  that  such  recognition reveals  specificities  that  are 
unique to the infected state,  such as viral-encoded determinants that  are expressed 
only on the surface of infected ceils  and are not  present  or accessible in  the intact 
virion. In an effort to determine the extent to which the recognition by monoclonal 
antibodies  of PR8-infected cells  could be  attributed  to the presence of cell  surface 
antigens,  particularly  those  encoded  by the  MHC,  binding was  assessed  on  PR8- 
infected kidney fibroblasts derived from MHC allogeneic strains. 
Table II represents an analysis of 93 monoelonal antibodies derived from BALB.K 
B cells  stimulated with  PR8-infected L929 cells  that  bound PR8-infected BALB.K 
kidney fibroblasts but not the purified PR8 virion. These antibodies were assessed  for 
their  ability  to  bind  PR8-infected  3T3  cells  of BALB/c origin  (H-2  d)  and  PR8- 
infected C57BL/6 kidney fibroblasts  (H-2b).  19% of the antibodies bound all  three 
PR8-infected cell  lines.  It is not possible at  this  time to delineate  from within  this 
particular  set  those  antibodies  that  may  have  recognized  virus  determinants  in 
conjunction with H-2 determinants common to all three strains as opposed to those 
antibodies that may have recognized viral antigens that are unique for infected cells 
or expressed in conjunction with non-H-2 cell surface antigens. 
A total of 21% of the antibodies recognized PR8-infected BALB.K cells  as well as 
only  one  of  the  other  two  infected  cell  lines.  As  a  result  of such  discriminate 
recognition, it is less likely that these antibodies recognized viral determinants unique 
to infected cells,  and it is more likely that these antibodies recognized PR8 determi- 
nants in conjunction with determinants expressed on H-2-encoded molecules. If this 
is so, it would imply that antibody recognition of viral antigenic determinants includes 
recognition of H-2 determinants shared by different haplotypes. Finally, the majority 
of antibodies  (60%) were restricted to recognition of only the H-2 syngeneic-infected 
cell line. Whereas the limited extent of the panel used in these studies does not permit 
an unambiguous attribution of these latter specificities, such complex recognition of 
PR8 determinants and determinants unique to H-2  k antigens would be most consistent 
with the H-2-restricted recognition generally associated with T  cell specificity (9). 
To further  define  the  precise  recognition of these  antibodies,  24 antibodies  that 
recognized PR8-BALB.K-infected cells  and not cells  of the two different haplotypes 
were analyzed for their capacity to bind PR8-infected kidney fibroblasts derived from 
two  strains  expressing  either  the  K  end  or  D  end  of  the  H-2  k  haplotype.  The 
reactivities  of these  antibodies  are  shown  in  Table  III.  One  of these  antibodies 
recognized both PRS-infected C3H.OH (Kd,D  k) and PR8-infected B 10.A(4R) (Kk,D  b) 
kidney cells and therefore, may have recognized either a determinant shared by both 
TABLE II 
MHC Restriction of Infected Cell-specific Monoclonal Antibodies* 
PR8-BALB.K (H-2  k)  PRS-3T3  (H-2  d)  PR8-B6 (H-2  b)  Number  Percent 
+  -  -  56  60 
+  +  -  lO  11 
+  -  +  9  10 
+  +  +  18  19 
* The monoclonal antibodies in this analysis were obtained from BALB.K  donor spleen cells stimulated 
with PR8-infected L929  cells and include only those that recognized  both infected L929  cells and infected 
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TABLE  III 
H-2 Gene Products Recognized by PR8-H-2k-specific Monoclonal Antibodies* 
PR8-C3H.OH  PRS-B 10.A(4R)  Number of  Percent of 
(Kd,D  k)  (Kk,D  b)  antibodies  total 
+  -  18  81 
-  +  3  14 
+  +  1  5 
* The  monoclonal antibodies in  this analysis were obtained  from BALB.K 
donor spleen cells stimulated with PR8-L929 cells and include only those 
that  recognized PR8-infected BALB.K cells but  not  PR8-infected 3T3  or 
C57BL/6 cells (from Table II). 
TABLE  IV 
1-1-2 Gene Products Recognized by PR8-H-2b-specific Monoclonal Antibodies* 
PR8-BALB.B  PR8-B10.A(5R)  PR8-D2.GD  Number of  Percent of 
(Kb,D  b)  (Kb,D  d)  (Kd,D  b)  antibodies  total 
+  +  -  40  73 
+  -  +  0  0 
+  +  +  15  27 
* The monoclonal antibodies in this analysis were obtained from C57BL/10  donor 
spleen cells stimulated with PR8-infected EL4 cells and  include only those that 
recognized PRS-infected BALB.B cells but not purified virus or uninfected cells. 
TABLE  V 
Reactivity Pattern Analysis of PR-8-infected H-2I~ Cell-specific Monoclonal 
Antibodies against PR8-infected H-2I~ Mutant Kidney Fibroblasts* 
bm9  +  +  +  +  -  -  - 
bml0  +  +  +  +  - 
bmll  +  -  -  +  +  -  + 
bml  bm4  bm8 
+  +  +  65 
+  +  -  --  3  3 
+  ....  3 
+  -  +  --  3 
-  +  + 
--  +  -- 
--  -  +  24 
-  -  -  18  3  3 
16  6 
3  --  3  --  6 
* The monoelonal antibodies in this analysis were obtained from C57BL/10  donor 
spleen cells stimulated with PR8-EL4 cells and include only those that recognized 
PR8-infected B10.A(5R) cells but not PR8-infected D2.DG cells (from Table IV). 
~: Results are expressed as percentage of 36 monoclonal antibodies showing a  partic- 
ular reactivity pattern. 
the  K  end  and  D  end  of H-2 k  or,  alternatively,  a  non-H-2  determinant  expressed 
neither  on  the  PR8-infected  3T3  nor  B6  cells.  Three  antibodies  (12%)  recognized 
PR8-infected  B10.A(4R)  cells  but  not  PR8-infected  C3H.OH  cells,  indicating  that 
the  specificity of these  antibodies  may  be  ascribed  to  the  recognition  of the  H-2K k- 
encoded  determinants  in  conjunction  with  PR8  determinants.  The  vast  majority  of 
monoclonal  antibodies  (81%)  recognized  PR8  only  in  the  context  of cells syngeneic 
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recognition of influenza-infected H-2  k cells, wherein the restriction appears to favor 
K  end recognition (9). 
To examine the generality of these findings and also to enable an unambiguous 
delineation of the H-2 contribution to determinant recognition, a similar analysis was 
carried  out  using  monoclonal antibodies  derived  from  C57B/10  B  cells  that  had 
responded  to  PR8-infected  EL-4  cells  (H-2b).  As  mentioned  above,  >60%  of the 
antibodies derived from this stimulation demonstrated unique recognition of virus in 
conjunction  with  infected  cells.  55  monoclonal  antibodies  that  recognized  PR8 
determinants in conjunction with BALB.B-infected kidney fibroblasts were analyzed 
for their capacity to bind PR8-infected B 10.AOR  ) (Kb,D  6) and PR8-infected D2.GD 
(Kd,D  b)  kidney fibroblasts.  In Table IV  it can be seen that  15 of these antibodies 
bound to both cell lines. Because these antibodies were not prescreened for dependence 
of their recognition on the expression of H-2  b per se, the specificity of these antibodies, 
like some of those in Table II, could not be attributed to the expression of a particular 
cell surface antigen.  Surprisingly, the remaining 40 antibodies appeared to require 
the presence of the H-2K  b molecule to effect recognition. Such specificity differs from 
CTL recognition of influenza-infected H-2  b cells where the predominant recognition 
is apparently for the D  end of the H-2  b haplotype (9). 
To demonstrate the participation of the H-2K  b molecule per se in the recognition 
of these monoclonal antibodies, an analysis was carried out with 36 of the monoclonal 
antibodies whose specificity depended on the presence of both PR8 and H-2K  b, using 
a  panel comprised of PR8-infected kidney fibroblasts derived from six different H- 
2K  b mutant strains. These mutants differ from the strain of origin by only one or two 
amino  acid  substitutions  in  the  K b molecule  (22).  The results  of this  analysis  are 
presented in Table V. It can be seen that only two of these antibodies (6%) recognized 
not only H-2K  b but all of the mutants as well. The remaining 34 antibodies bound to 
PR8-infected H-2K  b cells but did not bind to one or more of the panel of infected K b 
mutants. Thus, even antibodies (included in this analysis) that delineate quite closely 
related HA structures can, at the same time, discriminate H-2-encoded molecules at 
the  level  of single  amino  acid  replacements.  Additionally,  it  appears  that  these 
antibodies recognize a heterogeneous set of restricting elements in their recognition of 
H-2K  b determinants. 
Discussion 
The finding that  immunologically competent cells can be restricted to the recog- 
nition of a  variety of antigenic determinants only in the context of cells expressing 
syngeneic H-2-encoded antigens has generated considerable interest in the mechanistic 
basis  for  complex  antigenic  recognition  (2,  6-8,  23-26).  Although  such  complex 
recognition is characteristic of T  cell specificity, there have been reports that imuno- 
globulins can also be restricted to the recognition of certain antigenic determinants in 
the context of cell surface antigens  (10,  11).  Similarly, although many studies have 
indicated that B cell stimulation need not be haplotype restricted (4, 27-29), a  few 
recent investigations have implied that under certain conditions B cells may only be 
stimulated  by  antigen  presented  in  the  context  of cells  of an  appropriate  H-2 
haplotype (12-15). 
Because the antibody combining site for antigen has been carefully defined at the 
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in conjunction  with determinants of cell surface antigens encoded by the H-2 locus 
could serve as excellent models for defining potential mechanisms of complex antigen 
recognition.  To  maximize  the  chances  of observing antibodies  exhibiting  complex 
recognition, we analyzed B cell responses at the monoclonal level against  influenza 
infected cell lines, an antigenic system for which complex recognition by cytotytic T 
lymphocytes has been carefully established  (9,  20,  32).  It was reasoned  that  at  the 
monoclonal level antibodies recognizing viral determinants per se would not obscure 
the detection of antibodies whose binding required both viral antigenic determinants 
and  antigenic  determinants  contributed  by  cell  surface  antigens.  In  a  previous 
publication (16), we demonstrated the general parameters for obtaining this response 
and verified the efficacy of the stimulatory regimen on the basis that the component 
of the monoclonal response to influenza-infected cells that also recognized influenza 
determinants  on  the  purified  virion  was comparable in  frequency  and  diversity to 
responses to the same determinants when the purified virion was used for stimulation. 
The  findings  revealed  that  superimposed  on  the  monoclonal  response  of  B  cells 
recognizing  virion  determinants  per  se  was  an  even  more  vigorous  response  that 
recognized influenza determinants uniquely presented on the cell surface. 
The findings in this report demonstrate that the majority of monoclonal antibodies 
uniquely  specific  for  PR8-infected  cells  are  dependent  for  their  binding  on  the 
simultaneous presence of viral determinants and determinants of cell surface antigens 
encoded  within  the  H-2  locus.  It  is  important  to  point  out  that  this  recognition 
phenotype is not a rare or fortuitously occurring specificity. For example, in C57BL/ 
10 mice approximately 1 in 60,000 splenic B cells of conventional nonimmune mice 
recognizes HA determinants  present  only on infected cells, whereas  1 in  150,000  B 
cells recognizes HA determinants expressed on the virion. In view of these results, it 
is  possible  that  at  least  some  antibodies  that  appear  to  recognize  isolated  virion 
determinants  may also recognize complex determinants,  including  cell surface anti- 
gens, but recognize virion determinants with a sufficient affinity in the absence of cell 
surface antigens to be detected by radioimmunoassay using the virion alone. 
The  use  of the  influenza  antigen  in  this  study  was  predicated  in  part  on  the 
availability of a set of closely related viruses characterized by small differences within 
the HA moiety. Because monoclonal antibodies discriminate determinants shared to 
a greater or lesser extent amongst these variants, it has been possible to obtain a high 
degree of repertoire resolution of monoclonal antibodies recognizing the PRS-HA on 
the basis of reactivity pattern analysis  (16,  18).  Such  an analysis carried out on the 
monoclonal antibodies that required both determinants of the influenza hemaggluti- 
nin and cell surface antigens have proven quite revealing in two ways. First, the fact 
that  these  antibodies  discriminate  amongst  cells  infected  with  influenza  strains 
differing primarily in HA affixes the specificity, in terms of virus recognition by these 
antibodies,  to  the  HA  moiety.  Second,  the  determinants  recognized  by antibodies 
exhibiting  complex  recognition  appear  to  be  predominantly  "private"  PRS-HA 
specificities or determinants shared by very few H1 strains. The finding that the HA 
determinants  recognized  by  these  antibodies  is  not  a  random  representation  of 
potential HA determinants may indicate considerably greater constraints with respect 
to  the  breadth  of determinant  recognition  in  antibodies  that  must  simultaneously 
discriminate cell surface antigens as well as viral antigens. Studies  (32)  of the precise 
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recognition have not progressed sufficiently to reveal whether such specificity con- 
straints are unique to B cells that recognize complex antigenic determinants. 
It  remains  a  possibility  that  some  of the  monoclonal antibodies  that  recognize 
influenza determinants only in the context of an infected cell are recognizing influenza 
components that  are uniquely present on the cell surface and  not  available in the 
mature virion. This is particularly true of those monoclonal antibodies whose speci- 
ficity could not  be affixed to a  given H-2 determinant  by virtue of the panels of 
allogeneic or mutant H-2 strains used. Similarly, it is possible that within this set of 
antibodies are those that recognize influenza determinants in the context of non-H-2 
cell surface antigens.  In view of such potential recognitions, it is perhaps surprising 
that so great a  majority of PR8-infected cell-specific monoclonal antibodies depend 
on the expression of H-2 determinants for their binding. Thus, it would appear that, 
similar  to  restrictions  observed  in  the  T  cell  repertoire,  the  B  cell  repertoire  is 
significantly skewed towards recognition of complex antigens involving both viral and 
H-2-encoded determinants. 
Also similar to T cells specific for influenza-infected syngeneic cells, antibodies show 
a  clear preference for PR8 plus antigens encoded by only one end of a  given H-2 
haplotype. However, there is a striking disparity between the T  and B cell repertoires 
of the H-2 haplotypes analyzed, in that the preference of BALB.K antibodies was for 
antigens encoded by the D  end of the H-2  k locus, and the preference of C57BL/10 
antibodies was for the K end of the H-2  b locus. Previous reports (9) for CTL specificity 
of influenza-infected H-2  k and H-2  b cells by syngeneic CTL have revealed the opposite 
preference in both instances. Although a sample of two haplotypes is an inadequate 
base for firm conclusions, if subsequent studies of other haplotypes and other antigens 
reveal similar  disparities,  such  findings  could  reflect significant  differences in  the 
processes responsible for establishment and selection of the T  vs. B cell repertoires. In 
considering the high proportion of infected cell-specific antibodies that are restricted 
by H-2  K  or D  end  molecules, it  is  important  to note that  these findings  do not 
address the possibility of I-region-restricted influenza-specific antibodies, as the stim- 
ulatory cells used in these studies were tumor cells that do not bear I-region antigens. 
The most convincing evidence for the participation of determinants of H-2 antigens 
in the binding of antibody to PR8-infected cells comes from the analysis of the panel 
of PR8-infected H-2K  b mutant kidney fibroblasts. Of the monoclonal antibodies that 
recognized PR8 only in the context of the K  end antigens of the H-2  b locus, the vast 
majority could be discriminated by their inability to bind certain PR8-infected H- 
2K  b mutant cells. Other than the relatively low recognition of the infected bm 1 line, 
which appears to share the fewest determinants with the native H-2K  b molecule by 
monoclonal CTL analysis (33), little in the way of parallel reactivities between CTL 
recognition of the H-2K  b mutants and the recognition of these mutants in conjunction 
with PR8 by monoclonal antibodies could be observed. Nonetheless, the finding that 
the vast  majority of monoclonal antibodies could be discriminated  by the mutant 
panel  is  consistent  with  the  finding that  some mutations suffice to  totally restrict 
recognition of CTL for viral-infected syngeneic cells  (34).  Taken at  face value, the 
finding that a significant proportion of monoclonal antibody molecules discriminates 
simultaneously both H-2K  b mutants and viral HA variants represents strong evidence 
for recognition by antibodies of complex antigenic determinants as opposed to H-2 
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The findings  in  this  report introduce  firm evidence that  not  only T  cells but  a 
substantial proportion of B cells may have their specificity determined by both viral 
and H-2 antigenic determinants.  Because antibody molecules express singular com- 
bining sites, these findings demonstrate that complex recognition can be accomplished 
by a single combining site, thus obviating the necessity for proposing two independent 
and different receptors to account for complex antigen recognition. The demonstration 
of the relatively high frequency and relative ease of obtaining monoclonal responses 
to complex antigens that include determinants encoded by the MHC should provide 
fertile ground for future investigations of potential parallels in restriction and expres- 
sion of the B and T  cell repertoires. 
Summary 
The capacity of the antibody repertoire to recognize complex antigens  on viral- 
infected cells was investigated at the level of monoclonal B cell responses. A majority 
of primary B cells responsive to PRS(H1N1)-infected H-2 syngeneic ceils produced 
antibody that bound viral determinants only in the context of infected cells and not 
the isolated virion. An examination of the fine specificity of such antibodies revealed 
that  most  could be distinguished  by a  panel  of cells  infected with closely related 
heterologous HI  influenza strains.  Indeed,  most  antibodies  bound  hemagglutinin 
determinants of PR8 exclusively, and few were broadly cross-reactive. An examination 
of the same antibodies for their recognition of cell surface antigens revealed that the 
majority recognized MHC-encoded antigenic determinants. Thus, most BALB.K (H- 
2  a)  primary B cells responsive to PRS-L919 (H-2  k)  cells produced monoclonal anti- 
bodies that  bound  PRS-antigens only in  the context of H-2Dk-infected cells.  Most 
C57BL/10 (H-2  b)  B cells responsive to PRS-EL4 (H-2  b)  cells produced monoclonal 
antibodies that bound PR8 antigens only in the context of H-2Kb-infected cells. These 
latter antibodies were further shown to recognize that  H-2K  b molecule by virtue of 
their capacity to be discriminated by a  panel of PR8-infected H-2K  b mutant cells. 
These findings demonstrate that much of the antibody repertoire is capable of highly 
specific complex recognition of viral  antigenic  determinants  in  the  context of the 
appropriate MHC alloantigen. 
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